Latest Industry Insights

Change management is becoming an increasingly important part of company culture. This article explores how effective change management can reap significant benefits.

Renewed efforts to tap cyanobacteria, algae and plants in arenas typically dominated by heterotrophic systems are already beginning to yield fruit. In this article, we explore the inherent value of photosynthetic biotechnologies and their challenges.

Shark-derived squalene is a common adjuvant product found in several approved vaccines. As calls for a sustainable source of squalene increase, researchers are exploring how yeast can be used to produce squalene analogues.

Through automating processes and workflows, scientists can optimize their time and concentrate on high-value tasks. At SLAS 2023, Technology Networks interviewed Lars Kristiansen, general manager of Agilent’s Automation Solutions Business. We discussed Agilent’s automation portfolio that was showcased at the event, in addition to trends and challenges in automation.

Automated liquid handling methods are an attractive alternative to manual approaches, allowing labs to redirect important resources. At SLAS 2023, Technology Networks spoke with Thermo Fisher Scientific to discuss how automated liquid dispensing can support versatility in biotech.

In this opinion piece, Liz Sparrow discusses the real risk of the UK losing its science and technology communities as they face a series of challenges that are threatening their growth.

Dr. Adam Crowe sheds light on why a newly discovered reactive impurity is detrimental to mRNA function and how it can be detected more accurately.

To learn more about T-cell testing, the types of diseases it can help to diagnose and its value in clinical trials, we spoke to Phill Keefe, chief executive officer of PerkinElmer’s Oxford Immunotec division.

This article discusses how library-based approaches in quantitative proteomics can increase the sensitivity and accuracy of such detection systems.

To learn more about the Pioneer Antibody Discovery Platform and its potential impact on drug discovery and development, we spoke to Dr. John Cardone.